Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Compact Generation Flow Cytometers Offer Total Workflow Solution

By LabMedica International staff writers
Posted on 30 Jul 2009
Compact, affordable flow cytometers offer a total workflow solution that will include optimized reagent kits for clinical and life science applications, as well as in-field service. More...
The new flow cytometers will permit laboratory personnel to conduct analyses at their benchtops.

The new guava easyCyteT 8HT flow cytometry system is a compact, six-color detection system with 96-well automation. Six targets and eight parameters can be simultaneously analyzed in a single sample of cells. The system allows freedom to choose fluorescent dyes with well-separated emission spectra, which reduces the chance of overlap in the resulting signals and improves data quality.

The easyCyte 8HT system utilizes microcapillary technology that reduces the number of cells needed for analysis and the amount of waste generated--from liters per day with traditional approaches to less than 50 mL per day. Elimination of complicated fluidics gives the instrument a small footprint and dramatically decreases user maintenance.

The InCyte software allows investigators to view, compare, and analyze up to eight data sets simultaneously. This means that entire plates of data can be analyzed in less time than it currently takes to analyze data from a single sample using traditional software.

The new generation Guava easyCyteT 8HT flow cytometry system was launched by Millipore Corp. (Billerica, MA, USA) a provider of technologies, tools, and services for the global life science industry. It is the first instrument introduced by Millipore since its acquisition of Guava Technologies, a provider of benchtop flow cytometers, in February 2009.

Related Links:
Millipore Corp.



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.